Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
F45 Training operates a global network of franchised fitness studios offering high-intensity, functional group workouts. The company has recently expanded into wellness by partnering with telehealth provider Dr. B to support members using GLP-1 weight loss medications, integrating virtual training and nutrition programs for holistic health and longevity[6][7]. It went public in July 2021 but delisted from NYSE in August 2023 after financial challenges[1].
There are no clinical results as it does not conduct clinical trials typical of biotech/pharma companies.Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on F45 Training.